Reporter Aug 1 2014

Low selenium and lung cancer

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.

Drug discovery clues in network map

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

Radiation Oncology’s Malcolm to step down

Arnold Malcolm, M.D., MBA, the Cornelius Vanderbilt Professor of Radiation Oncology and chair of the department, will retire from his position as the department’s leader on Dec. 31, after serving in this role since August 2010.

Anti-inflammatory protein “rheostat” sheds light on leaky blood vessels

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.


Doris Duke awards enhance clinical research training

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.

VUMC to bring renewed focus to Elevate principles

Affirming that its people are Vanderbilt University Medical Center’s most important asset, the coming year will bring a renewed focus to Elevate, a Medical Center cultural touchstone.

1 2